NAD+ and Perimenopause: Can It Really Help With Fatigue or Brain Fog?
NAD+ is essential to cellular energy metabolism, DNA repair, and redox reactions. That basic science is real. The leap from “NAD+ is biologically important” to “an infusion or injection will fix perimenopause fatigue” is where the evidence becomes much less certain.
- What NAD+ does
- Why levels change with age
- Evidence for perimenopause
- IV vs oral products
- Brain fog and fatigue
- Safety and cost
- What to check first
Why NAD+ Became a Midlife Wellness Trend
Fatigue, poor sleep, reduced exercise tolerance, and brain fog are common complaints during the menopausal transition. NAD+ marketing offers a simple cellular explanation for a complicated symptom cluster, often using language about mitochondrial decline, depletion, and restoration.
What Human Evidence Can and Cannot Tell Us
Studies of NAD+ precursors have examined biomarkers and selected metabolic outcomes, but evidence for meaningful relief of perimenopause symptoms remains limited. IV NAD+ protocols vary, and high-quality trials demonstrating that they treat hot flashes, sleep disruption, cognitive complaints, or menopause-related fatigue are lacking.
Common Causes That Deserve Attention First
Night sweats and insomnia can directly produce daytime fatigue and concentration problems. Iron deficiency, thyroid disease, depression, anxiety, sleep apnea, medication effects, alcohol, and inadequate calories or protein may also contribute. Treating the cause is more reliable than assigning every symptom to low NAD+.
Supplement, Injection, and Infusion Are Not the Same
Oral nicotinamide riboside, nicotinamide mononucleotide, intramuscular products, and IV NAD+ have different pharmacology, evidence, cost, and quality concerns. They should not be grouped together as one proven treatment.
A Reasonable Standard for Trying a Wellness Intervention
Know what outcome you are measuring, avoid replacing necessary medical evaluation, review interactions and pregnancy status, and stop if adverse effects occur. Be wary of packages that require large upfront spending while promising detoxification, anti-aging, and hormonal restoration at once.
Products labeled for research use are not approved for self-treatment. When an approved prescription pathway exists, work through a licensed clinician and legitimate pharmacy.
For laboratory research only. These products are not approved for self-treatment or human consumption.
Frequently Asked Questions
Not sure which peptide fits your goal?
Take the 60-second quiz for a personalized educational starting point.
Take the Quiz →Compare this guide with our menopause, perimenopause, women-over-40, female libido, PT-141 approval, BPC-157, NAD+, and peptide-delivery explainers. These pages are designed to answer different versions of the same question without pretending one peptide fits every woman.
Menopause peptides · Perimenopause peptides · Peptides for women over 40 · Female libido peptides · Is PT-141 FDA approved? · BPC-157 for women · NAD+ and perimenopause · Oral vs injectable peptidesRelated Reading
FDA compounding safety information: https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
FDA compounding Q&A: https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
National Institute on Aging menopause overview: https://www.nia.nih.gov/health/menopause/what-menopause
Vyleesi prescribing label: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=BREMELANOTIDE